MEDIPOST has been designated institution which will carry out research projects of Ministry of Commerce, Industry and Energy together with Amore Pacific and Joongang University Hospital and will start R&D of hair growth solution using stem cells.

MEDIPOST announced that it has been selected as the research institution for ‘Bio Medical Instrument Original Technology Development Project’ of latter half of 2013 headed by Korea Evaluation Institute of Industrial Technology under Ministry of Commerce, Industry and Energy.

The research project selected this time is ‘Development of Hair Loss Prevention and Hair Growth Medicine using Protein Produced by Cord Blood which Stimulates Division of Hair Follicle Tissue’ and 3 organizations including MEDIPOST will introduce research capital of KRW2.5 billion with government aid.

Stem cell research is a field where Korea has globally high competitiveness, and in particular because there are almost no effective products in the hair growth field, much attention is being gathered by this research.

In this research, MEDIPOST and Amore Pacific will carry out hair growth optimization of stem cells and development of final product, and Joongang University Hospital research team will carry out mechanism research and pre-clinical/clinical studies.

This research has the goal of development a new concept hair loss treatment drug different to existing products on basis of stem cell treatment drug development experiences of MEDIPOST, and because research results which will support this has been already secured through prior research, a positive result is anticipated.